Why Regeneron win is worse for Amgen than you think?
Amgen patent covering LDL cholestrol lowering drug Reapatha are likely to be invalidated in the wake of a courtbattle with Regeneron Pharmaceutical and Sanofi. Recently, a federal judge tossed an injunction on sales of Praluent, Regenron and Sanofi will argue that Amgen's patent are too broad. The judge's decision on Thursday effectively ended [...]